AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA)
Clinical trials for AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA) explained in plain language.
Never miss a new study
Get alerted when new AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA) trials appear
Sign up with your email to follow new studies for AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take aim at stubborn blood disorder
Disease control Not yet recruitingThis early-phase trial tests a new therapy called META 10-19 for people with autoimmune hemolytic anemia (AIHA) that has not responded to standard treatments. AIHA is a condition where the immune system mistakenly destroys red blood cells, causing anemia. META 10-19 uses a patien…
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA)
Phase: EARLY_PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New drug combo aims to tame stubborn blood disorders
Disease control Not yet recruitingThis early-phase study tests whether combining two drugs (Zuberitamab and Orelabrutinib) can help people with immune thrombocytopenia (ITP) or autoimmune hemolytic anemia (AIHA) that hasn't responded to other treatments. The drugs work together to calm the immune system and stop …
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA)
Phase: PHASE1 • Sponsor: Qi deng • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New combo aims to tame autoimmune anemia without Long-Term steroids
Disease control Not yet recruitingThis study tests whether adding sirolimus to standard steroid treatment helps people with newly diagnosed mild autoimmune hemolytic anemia (AIHA) achieve lasting remission. About 216 adults will be randomly assigned to get either steroids alone or steroids plus sirolimus for 6 mo…
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA)
Phase: NA • Sponsor: Chen Miao • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC